[HTML][HTML] Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis

OH Nielsen, JM Gubatan, CB Juhl, SE Streett… - Clinical …, 2022 - Elsevier
Background & Aims Biologics are used routinely in pregnant women with inflammatory
bowel disease (IBD), but large-scale data reporting adverse pregnancy outcomes among …

Sex matters: impact on pathogenesis, presentation and treatment of inflammatory bowel disease

WA Goodman, IP Erkkila, TT Pizarro - Nature Reviews Gastroenterology …, 2020 - nature.com
Inflammatory bowel disease (IBD), as do most chronic inflammatory disorders, displays
unique features and confers different risk factors in male and female patients. Importantly …

Pregnancy and neonatal outcomes after fetal exposure to biologics and thiopurines among women with inflammatory bowel disease

U Mahadevan, MD Long, SV Kane, A Roy… - Gastroenterology, 2021 - Elsevier
Background & Aims Pregnant women with inflammatory bowel disease (IBD) may require
biologic or thiopurine therapy to control disease activity. Lack of safety data has led to …

Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti‐TNF or conventional therapy: results of the European CONCEIVE study

A Moens, CJ van der Woude… - Alimentary …, 2020 - Wiley Online Library
Background Women with inflammatory bowel diseases (IBD) often receive biologicals
during pregnancy to maintain disease remission. Data on outcome of vedolizumab‐exposed …

European Crohn's and colitis guidelines on sexuality, fertility, pregnancy, and lactation

J Torres, M Chaparro, M Julsgaard… - Journal of Crohn's …, 2023 - academic.oup.com
2. Methods This document represents the third version of the European Consensus on
reproduction in IBD. The development of this Consensus included the formulation of …

The role of TNF-α and anti-TNF-α agents during preconception, pregnancy, and breastfeeding

K Romanowska-Próchnicka, A Felis-Giemza… - International journal of …, 2021 - mdpi.com
Tumor necrosis factor-alpha (TNF-α) is a multifunctional Th1 cytokine and one of the most
important inflammatory cytokines. In pregnancy, TNF-α influences hormone synthesis …

Safety of ustekinumab or vedolizumab in pregnant inflammatory bowel disease patients: a multicentre cohort study

P Wils, P Seksik, C Stefanescu… - Alimentary …, 2021 - Wiley Online Library
Background The prevalence of inflammatory bowel diseases (IBD) is high in women of
childbearing age. Achieving clinical remission from conception to delivery using current …

Longitudinal changes in fecal calprotectin levels among pregnant women with and without inflammatory bowel disease and their babies

ES Kim, L Tarassishin, C Eisele, A Barre, N Nair… - Gastroenterology, 2021 - Elsevier
Background & Aims The effect of pregnancy on inflammatory bowel disease (IBD) remains
poorly understood. We aimed to monitor intestinal inflammation using fecal calprotectin (FC) …

Monoclonal antibody treatment during pregnancy and/or lactation in women with MS or neuromyelitis optica spectrum disorder

AI Ciplea, A Langer-Gould, A de Vries… - Neurology …, 2020 - AAN Enterprises
Objective To assess possible adverse effects on breastfed infants of mothers receiving
monoclonal antibodies (MAbs) during pregnancy and/or lactation. Methods We identified 23 …

[HTML][HTML] Ciprofloxacin

T Thai, BH Salisbury, PM Zito - StatPearls [Internet], 2023 - ncbi.nlm.nih.gov
Ciprofloxacin - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …